Owen M J MJ - OmicsDI

Show results for

Unknown (455)
Genomics (27)
Metabolomics (8)
Models (3)
Transcriptomics (3)

Organisms

Homo sapiens (27)
Arabidopsis (3)
Caenorhabditis elegans (3)

Repository

EGA (27)
MetaboLights (8)
BioModels (3)
biostudies-arrayexpress (3)

Technology Type

Illumina 15K (8)
Mass spectrometry (5)
NMR spectroscopy (2)
Mass spectrometry assay (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
Nuclear Magnetic Resonance (NMR) - (2)
Liquid Chromatography MS - positive (1)

Publication Date

2023 (5)
2024 (4)
2010 (3)
2025 (1)
2020 (1)

UNIPROT ID/AC

Q9XFM0 (2)
Q940U6 (2)
Q9LPW7 (1)
Q9LW29 (1)
Q9ZR12 (1)
Q570C0 (1)
Q9LQT8 (1)
Q9MAA7 (1)
P49677 (1)

CHEBI ID

CHEBI:35038 (3)
CHEBI:16359 (3)
CHEBI:28865 (3)
CHEBI:143757 (2)
CHEBI:182784 (2)
CHEBI:195271 (2)
CHEBI:143745 (2)
CHEBI:139138 (2)
CHEBI:34494 (2)
CHEBI:80774 (2)
CHEBI:34687 (2)
CHEBI:173703 (2)
CHEBI:64563 (2)
CHEBI:27432 (2)
CHEBI:73858 (2)
CHEBI:75342 (2)
CHEBI:27997 (2)
CHEBI:32906 (1)
CHEBI:29590 (1)
CHEBI:29605 (1)
CHEBI:32902 (1)
CHEBI:30088 (1)
CHEBI:181874 (1)
CHEBI:195266 (1)
CHEBI:195267 (1)
CHEBI:195265 (1)
CHEBI:166710 (1)
CHEBI:181126 (1)
CHEBI:195264 (1)
CHEBI:25640 (1)

Metabolite Name

Tris(2-butoxyethyl) phosphate (3)
Cholic acid (3)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Dibutyl phthalate (DBP) (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
Elaidic acid (2)
Monoolein (2)
Lyso-PC(16:0) (2)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
Taurocholic acid (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
9(10)-EpOME (2)
L-Lactic acid (2)
Glycine (2)
Formic acid (2)
Choline (2)
Acetic acid (2)
L-Histidine (2)
L-Carnitine (2)
L-Leucine (2)
L-Tyrosine (2)
L-Isoleucine (2)
L-Glutamine (2)
L-Phenylalanine (2)
L-Alanine (2)
L-Valine (2)
Creatinine (2)
Citric acid (2)

IsPrivate

False (3)

Modelling Approach

Ordinary differential equation model (3)

Study type

Transcription profiling by array (3)

Release Date

2023 (50)
2021 (41)
2020 (36)
2024 (32)
2022 (32)
2019 (28)
2025 (27)
2018 (27)
2015 (24)
2017 (22)
2014 (21)
2012 (21)
2016 (19)
2013 (19)
2011 (17)
2010 (11)
2009 (10)
2008 (10)
2026 (7)
2007 (3)
2006 (1)

Previous page
1 / 50
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 50
Next page

Sort by:

Relevance

Page size

Middleton2012_GibberellinSignalling

This model is from the article: Mathematical modeling elucidates the role of transcriptional feedback in gibberellin signaling. Middleton AM , Úbeda-Tomás S , Griffiths J , Holman T , Hedden P , Thomas SG , Phillips AL , Holdsworth MJ , Bennett MJ , K...

2024-09-02 | BIOMD0000000422 | BioModels

Ex-Vivo Equine Cartilage Explant Osteoarthritis Model - A Metabolomics and Proteomics Study

Osteoarthritis (OA) is an age-related degenerative musculoskeletal disease characterised by loss of articular cartilage, synovitis, abnormal bone proliferation and subchondral bone sclerosis. Underlying OA pathogenesis is yet to be fully elucidated with no OA specific biomarkers in clinical use. Ex-...

2020-09-30 | MTBLS1495 | MetaboLights

Band2012_DII-Venus_FullModel

This model is from the article: Root gravitropism is regulated by a transient lateral auxin gradient controlled by a tipping-point mechanism. Band LR, Wells DM, Larrieu A, Sun J, Middleton AM, French AP, Brunoud G, Sato EM, Wilson MH, Péret B, Oliva M, Swarup R, Sairanen I,...

2024-09-02 | BIOMD0000000413 | BioModels

Band2012_DII-Venus_ReducedModel

This model is from the article: Root gravitropism is regulated by a transient lateral auxin gradient controlled by a tipping-point mechanism. Band LR, Wells DM, Larrieu A, Sun J, Middleton A...

2024-09-02 | BIOMD0000000414 | BioModels

Metabolomic and Proteomic Stratification of Equine Osteoarthritis

Osteoarthritis (OA) is characterised by loss of articular cartilage, synovial membrane dysfunction and subchondral sclerosis. Few studies have used a global approach to stratify equine synovial fluid (SF) molecular profiles according to OA severity. SF was collected from 58 metacarpophalangeal (M...

2025-10-16 | MTBLS1645 | MetaboLights

The impact of the glycan headgroup on the nanoscopic segregation of gangliosides.

Not available

S-EPMC8715245 | biostudies-literature

Comparison of autism domains across thirty rare variant genotypes.

Not available

S-EPMC11835590 | biostudies-literature

Linking toxicant physiological mode of action with induced gene expression changes in Caenorhabditis elegans: cadmium

Physiologically based modelling using DEBtox (dynamic energy budget in toxicology) and transcriptional profiling were used in Caenorhabditis elegans to identify how physiological modes of action, as indicated by effects on system level resource allocation were associated with changes in gene express...

ORGANISM(S): Caenorhabditis elegans

2010-05-05 | E-GEOD-21010 | biostudies-arrayexpress

Linking toxicant physiological mode of action with induced gene expression changes in Caenorhabditis elegans: atrazine

ORGANISM(S): Caenorhabditis elegans

2010-03-23 | E-GEOD-21008 | biostudies-arrayexpress

Schizophrenia risk variants modulate white matter volume across the psychosis spectrum: evidence from two independent cohorts.

Not available

S-EPMC4375641 | biostudies-literature